One-year follow-up of plasma exchange therapy in 14 patients with idiopathic thrombocytopenic purpura. 1981

V J Marder, and J Nusbacher, and F W Anderson

Fourteen patients with idiopathic thrombocytopenic purpura (ITP) have been followed for one year after plasma exchange therapy. Exchange was performed prior to splenectomy in eight of nine patients with acute ITP and following splenectomy in five patients with chronic ITP. None with chronic ITP showed a response in platelet count as a result of exchange therapy. Four of the nine with acute ITP had poor responses and required splenectomy because of persistent severe thrombocytopenia. Three of these have responded completely and are in remission. One patient with acute ITP had an equivocal response, with a most recent platelet count of 93,000/microliter. The remaining four patients with acute ITP had prompt and complete responses and now have platelet counts above 100,000/microliter without steroid treatment. Although the good responses were temporally associated with the use of plasma but not albumin, the data are not sufficient to conclude that a plasma factor must be infused to obtain a satisfactory result. The overall response after one year was about that expected for acute ITP patients treated with prednisone and early splenectomy. Exchange plasmapheresis may be of value in decreasing the number of patients who require splenectomy, but a randomized, prospective study is needed to adequately assess this possibility.

UI MeSH Term Description Entries
D010951 Plasma Exchange Removal of plasma and replacement with various fluids, e.g., fresh frozen plasma, plasma protein fractions (PPF), albumin preparations, dextran solutions, saline. Used in treatment of autoimmune diseases, immune complex diseases, diseases of excess plasma factors, and other conditions. Exchange, Plasma,Exchanges, Plasma,Plasma Exchanges
D011696 Purpura, Thrombocytopenic Any form of purpura in which the PLATELET COUNT is decreased. Many forms are thought to be caused by immunological mechanisms. Purpura, Thrombopenic,Purpuras, Thrombocytopenic,Purpuras, Thrombopenic,Thrombocytopenic Purpura,Thrombocytopenic Purpuras,Thrombopenic Purpura,Thrombopenic Purpuras
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012709 Serum Albumin A major protein in the BLOOD. It is important in maintaining the colloidal osmotic pressure and transporting large organic molecules. Plasma Albumin,Albumin, Serum

Related Publications

V J Marder, and J Nusbacher, and F W Anderson
January 1984, Transfusion,
V J Marder, and J Nusbacher, and F W Anderson
August 1980, Archives of internal medicine,
V J Marder, and J Nusbacher, and F W Anderson
October 1981, [Rinsho ketsueki] The Japanese journal of clinical hematology,
V J Marder, and J Nusbacher, and F W Anderson
January 1990, Current studies in hematology and blood transfusion,
V J Marder, and J Nusbacher, and F W Anderson
September 1978, Lancet (London, England),
V J Marder, and J Nusbacher, and F W Anderson
June 1964, American journal of obstetrics and gynecology,
V J Marder, and J Nusbacher, and F W Anderson
April 1984, Canadian Medical Association journal,
V J Marder, and J Nusbacher, and F W Anderson
May 2001, Haematologica,
V J Marder, and J Nusbacher, and F W Anderson
November 1998, Surgical endoscopy,
V J Marder, and J Nusbacher, and F W Anderson
January 1992, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!